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ABSTRACT
Despite being a GOLD guideline and having documented benefits, confirming a COPD
diagnosis with spirometry is not routinely done. The purpose of this project was to increase
patient referrals for spirometry to confirm COPD diagnosis. A quasi-experimental design was
incorporated in a primary care office. A retrospective pre-intervention chart audit and two postchart audits, 30-days apart, compared the frequency of documented spirometry to confirm a
COPD diagnosis. An educational intervention with a pre and post-survey examined provider
behavior intention to order spirometry to confirm a COPD diagnosis. The pre-chart audit
revealed that 27/50 (54%) of patients had spirometry documented to confirm a COPD diagnosis.
Thirty-day post chart audit and feedback intervention revealed 33/50 (66%) and sixty-day post
chart audit and feedback intervention revealed 31/50 (62%) of patients had spirometry
documented to confirm a COPD diagnosis. The Z-test at 30 days revealed the P-value
corresponding to z-1.225 is 0.112. The Z-test from the pre-chart audit to the 60-day post-chart
audit revealed the P-value corresponding to z-0.8104 is 0.2088. The post-survey of 6 providers
revealed a behavior intention increase from 63.4% to 86.6%, a 23.3% increase in behavior
intention. Although there was not a statistically significant increase in the number of spirometry
referrals, there was a clinically significant increase. After implementing a chart audit and
educational intervention, the provider’s behavior intention also increased. Hence, a chart audit
and educational intervention may be helpful to improve primary care provider’s behavior
intention for specific clinical practice guidelines.
Keywords: Spirometry, COPD, primary care, chart audit.

SPIROMETRY AND COPD DIAGNOSIS

4

CHART AUDIT AND EDUCATIONAL PROVIDER FEEDBACK INTERVENTION TO
IMPROVE APPROPRIATE USE OF SPIROMETRY IN PATIENTS WITH CHRONIC
OBSTRUCTIVE PULMONARY DISEASE

©2018
Ruth Evangeline Demetros
ALL RIGHTS RESERVED

SPIROMETRY AND COPD DIAGNOSIS

5

Acknowledgements
First and foremost, I want to first thank the Lord for always being there for me, for
providing for all of my needs, and for guiding me through this entire process. His guidance and
unfailing love are more appreciated than I could ever express.
I am also grateful for my scholarly project chair, Dr. Murphy, DNP, FNP-BC, who
worked tirelessly with me to ensure a smooth and timely process. Your positivism and
dedication to assist and encourage me throughout this process has been so helpful. Thank you.
A special thank you to the medical director, the center manager, and to the primary care
providers who agreed to be a part of this project. Thank you for working with me to improve
patient care. Dr. Danner has helped this process to run very smoothly and efficiently, for which I
am grateful. Also, thank you to Brett Gallio for your assistance with the statistics. I could not
have done it without you.
To my parents, siblings, family, and friends, thank you for your continued assistance,
encouragement, and guidance throughout this entire process. Mom, you have always encouraged
me through the difficult times and you taught me how to improve my writing skills when I was a
young girl. You each have a special place in my heart and I am so grateful for the love I receive
from you all on a regular basis. Finally, thank you to Aldo Tropeano for encouraging my walk
with Christ, making me smile every day, and praying for my continued success. I could not have
made it through this process without you.

SPIROMETRY AND COPD DIAGNOSIS

6

Table of Contents
ABSTRACT ............................................................................................................................. 3
Acknowledgements ............................................................................................................... 5
Table of Contents .................................................................................................................. 6
List of Tables ......................................................................................................................... 8
List of Figures ........................................................................................................................ 9
List of Abbreviations ............................................................................................................ 10
Introduction ........................................................................................................................ 11
Background ......................................................................................................................... 12
Epidemiology of COPD ................................................................................................................. 12
COPD Diagnosis ........................................................................................................................... 12
Chart audit and Provider Feedback ............................................................................................... 16
Problem Statement ...................................................................................................................... 17
Purpose of the Project.................................................................................................................. 17
Clinical Question .......................................................................................................................... 17

Literature Review and Synthesis .......................................................................................... 17
Quality Critical Appraisal .............................................................................................................. 18
Systematic Reviews...................................................................................................................... 18
Clinical Practice Guidelines ........................................................................................................... 20
Randomized Controlled Trials ....................................................................................................... 22
Quasi-experimental Trials ............................................................................................................ 24
Other Evidence ............................................................................................................................ 25
Synthesis ..................................................................................................................................... 25
Conceptual Framework ................................................................................................................ 33
Summary ..................................................................................................................................... 36

Methodology....................................................................................................................... 37
Design ......................................................................................................................................... 37
Measurable Outcomes ................................................................................................................. 38
Setting, Population, Sample ......................................................................................................... 38
Ethical Considerations .................................................................................................................. 39
Intervention, Tool, Data Collection ............................................................................................... 40
Feasibility Analysis ....................................................................................................................... 42
Cost-Benefit Analysis ................................................................................................................... 43
Evaluation/Data Analysis ............................................................................................................. 43

Results ................................................................................................................................ 47
Demographics .............................................................................................................................. 47
Assumptions ................................................................................................................................ 48
Main Findings .............................................................................................................................. 48
Summary of Results ..................................................................................................................... 51

Discussion ........................................................................................................................... 52
Strengths ..................................................................................................................................... 52

SPIROMETRY AND COPD DIAGNOSIS

7

Limitations................................................................................................................................... 53
Implications for Practice............................................................................................................... 53
Implications for Research ............................................................................................................. 55
Dissemination plan ...................................................................................................................... 55

Conclusion........................................................................................................................... 56
References .......................................................................................................................... 58
Appendix A.......................................................................................................................... 64
Appendix B .......................................................................................................................... 83
Appendix C .......................................................................................................................... 84
Appendix D ......................................................................................................................... 85
Appendix E .......................................................................................................................... 86
Appendix F .......................................................................................................................... 87
Appendix G ......................................................................................................................... 88
Appendix H ......................................................................................................................... 89
Appendix I ........................................................................................................................... 90

SPIROMETRY AND COPD DIAGNOSIS

8

List of Tables
Table 1. Documented Spirometry Rate ........................................................................................ 49
Table 2. Spirometry Referral Trend ............................................................................................. 50

SPIROMETRY AND COPD DIAGNOSIS

9

List of Figures
Figure 1. Years of Provider's Experience. .................................................................................... 47
Figure 2. Type of Provider Healthcare Profession........................................................................ 48
Figure 3. Documented Spirometry Rate. ...................................................................................... 49
Figure 4. Spirometry Referral Trend. ........................................................................................... 50

SPIROMETRY AND COPD DIAGNOSIS
List of Abbreviations
American Thoracic Society (ATS)
Appraisal of Guidelines Research & Evaluation II tool (AGREE)
Centers for Disease Control and Prevention (CDC)
Centers for Medicare and Medicaid (CMS)
Chronic Obstructive Pulmonary Disease (COPD)
Collaborative Institutional Training Initiative (CITI)
European Respiratory Society (ERS)
Evidenced-Based Practice (EBP)
Forced Expiratory Volume (FEV)
Forced Vital Capacity (FVC)
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Lower Limit of Normal (LLN)
Nurse Practitioner (NP)
Physician Assistant (PA)
Primary Care Providers (PCP)
Probability Value (P-value)
Randomized Controlled Trial (RCT)
Risk Difference (RD)
Scottish Intercollegiate Guidelines Network (SIGN)
United States
Veterans Affairs

10

SPIROMETRY AND COPD DIAGNOSIS

11

Introduction
Chronic obstructive pulmonary disease (COPD) is a common, progressive, and
debilitating disease that affects many people worldwide on a daily basis. COPD is characterized
by an airway chronic inflammatory reaction from factors such as respiratory gases, especially
tobacco smoke (Ghattas et al., 2013). COPD is prevalent and imposes a major fiscal burden on
our global healthcare system. In 2010, COPD incurred approximately $50 billion from direct
and indirect expenses (Guarascio, Ray, Finch, & Self, 2013). COPD affects approximately 6.3%
of people in the United States, or 15 million adults (CDC, 2012). Current practice
recommendations by the Global Initiative for Chronic Obstructive Lung Disease (GOLD)
guidelines identify the significance of confirming a COPD diagnosis using spirometry (GOLD,
2017). Use of spirometry helps avoid misdiagnoses, determine prognosis, and guide treatment
(GOLD, 2017). Healthcare providers have a weighty responsibility to properly diagnose and
treat patients and must strongly consider the recommendations by reputable sources such as the
GOLD standards (GOLD, 2017).
Spirometry is an objective, readily available, and noninvasive method to confirm the
diagnosis of COPD (GOLD, 2017). Utilizing spirometry aids in avoiding misdiagnosing COPD,
indirectly reduces COPD readmissions, improves patient outcomes and safety concerns,
improves quality of life, is fiscally beneficial, and may ultimately reduce the global burden
COPD has on the health care system. Chart audit and performance feedback is an efficient
method to improve provider’s compliance with evidenced-based practice guidelines, such as the
usage of spirometry to confirm COPD diagnosis (Ivers et al., 2013). The purpose of this project
is to determine the effectiveness of using a chart audit and feedback method to educate primary
care providers on confirming COPD diagnosis with spirometry.
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Background
Epidemiology of COPD
COPD is a common disease, characterized by its chronic and progressive nature. It is a
major cause of morbidity and mortality around the world. It is the fourth leading cause of
mortality, and by 2020 is suspected to increase to the third main cause of death (GOLD, 2017).
The prevalence of COPD still continues to be high in the United States. Approximately 6.3% of
people in the United States, or 15 million adults suffer from COPD (CDC, 2012). COPD also
impacts morbidity and is associated with many co-morbid conditions. A large cross-sectional
study examined COPD and its co-morbidities in the primary care setting. These co-morbidities
include anxiety, depression, hypertension, and many others (Chetty et al., 2017). This study
concluded that patients with COPD are much more likely to have many physical and mental comorbidities that coincide with this disease than those who do not have COPD (Chetty et al.,
2017). Within the fiscal perspective, COPD causes a large burden on the global healthcare
system. In 2010, the amount of both direct and indirect expenses that COPD incurred summated
approximately $50 billion (Guarascio et al., 2013).
COPD Diagnosis
Providers have a responsibility to correctly diagnose and treat their patients to prevent
long-term complications and to delay the progression of a disease (Wood, 2014). Since COPD is
chronic and progressive, the earlier that an accurate diagnosis is made, the better the outcome
(Wood, 2014). In order to understand the importance of spirometry, COPD in general needs to
be briefly examined regarding risk factors, etiology, diagnosis, and clinical manifestations.
Tobacco smoke is the most common identified risk factor for developing COPD (GOLD,
2017). Other risk factors include being exposed to occupational and other air pollutants.
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Although nonsmokers can also develop COPD, the pathophysiology behind COPD involves a
conglomeration of exposure to harmful gases and specific host susceptibilities. These specific
host considerations include genetic components, asthma, history of pulmonary infections,
advanced age, female gender, and lower socioeconomic status (GOLD, 2017).
Signs and symptoms of COPD include chronic dyspnea, cough, and sputum production
(GOLD, 2017). The dyspnea is considered progressive in nature, is often exacerbated with
exercise, and persists (GOLD, 2017). A chronic cough of someone with COPD may be either
productive or non-productive in nature (GOLD, 2017). A patient who is suspected to have
COPD based on their symptoms of the chronic cough, dyspnea, and/or sputum production with
known risk factors are good candidates for spirometry evaluation to confirm the COPD diagnosis
(GOLD, 2017).
Spirometry, is considered the gold standard for diagnosing COPD (GOLD, 2017).
Spirometry is non-invasive and measures many aspects of one’s pulmonary capabilities
including capacity, lung volume, the rate of flow, and gas exchange, which helps the provider in
differentiating between multiple differential diagnoses (John Hopkins Medicine, n.d).
Spirometry specifically differentiates between an obstructive and a restrictive breathing pattern
based on the results of the testing (John Hopkins, n.d.). Spirometry measures various values to
determine these results including tidal volume, total lung capacity, forced vital capacity (FVC),
and forced expiratory volume (FEV), with the last two being most important to the diagnosis of
COPD (John Hopkins Medicine, n.d.). Spirometry is considered the gold standard for several
reasons including its non-invasive characteristics, feasibility, that it is readily available, highly
sensitive, reproducible, and objective (GOLD, 2017). Therefore, the 2017 guidelines identify
spirometry as essential in diagnosing COPD (GOLD, 2017).
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The cost of spirometry needs to be examined if it is recommended that primary care
providers should order them. According to the Centers for Medicare and Medicaid (CMS),
insurance coverage for spirometry will be provided if it is generally indicated (CMS, n.d.).
These indications include documentation that supports signs, symptoms, abnormal laboratory
testing, examination for preoperative risks, the patient’s prognosis, and/or the impact specific
diseases have on their pulmonary system (CMS, n.d.).
Spirometry usage benefits. Utilizing spirometry to confirm the diagnosis of COPD in
the primary care setting has many documented benefits. Some of these benefits include
spirometry assistance in avoiding misdiagnosing COPD, cost saving approaches, and reducing
the considerable burden COPD has on the healthcare system (Walters et al., 2011 & Fortis et al.,
2016). It also helps prevent COPD readmissions and improve the patient’s quality of
life/outcomes (Guerriero et al., 2015).
Despite all of the recommendations and positive characteristics, spirometry is still widely
underutilized in diagnosing COPD. This results in patients often being misdiagnosed with
COPD (Walters et al., 2011). In 2011, a cross-sectional study examined 341 patients in Australia
who were diagnosed with COPD (Walters et al., 2011). The 341 patients in the study were
examined using spirometry and the results identified 107 of those patients (31%), who did not
have COPD even though they were diagnosed based on their symptoms and had been prescribed
several inhalers (Walters et al., 2017). The study concluded that diagnosing COPD solely on
symptoms is unreliable in the primary care setting and that these patients need spirometry to
confirm their COPD diagnoses (Walters et al., 2017).
Incorrectly diagnosing a patient with COPD also impacts patient safety, results in
financial waste, and burdens the global healthcare system. A longitudinal population study that
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was conducted from 2005 to 2012 in Canada examined charts from patients who had been
diagnosed with COPD. The article identified 68,898 patients with COPD and noted that only
41.2% of these patients received spirometry (Gershon et al., 2017). The analyses concluded
those COPD patients who received spirometry were 9% less likely to be admitted to the hospital
for a COPD cause, or die for any reason, than those patients with COPD who did not have
spirometry completed (Gershon et al., 2017). Therefore, it appears that the number of primary
care patients who receive spirometry prior to their COPD diagnosis needs to be increased in
order to reduce morbidity and mortality as well as improve patient safety.
Spirometry also assists the provider in properly determining the severity of the patient’s
COPD. Without completing spirometry, the provider is likely to underestimate the severity of
their patient’s COPD (Mapel, Dalal, Johnson, Becker, & Hunter, 2015). A multicultural, crosssectional, observational study in the United States examined 899 patients who had COPD and
their providers, in order to determine whether the provider’s impressions of the severity of their
patients changed before and after spirometry (Mapel et al., 2015). Disease severity was realized
to be more severe than what had been thought in 17% and less severe in 5% of the patients after
spirometry testing resulted (p<0.05). Also, the treatment for about one-third of these patients
changed after they received spirometry since the understanding of their severity had also
changed (Mapel et al., 2105). Therefore, spirometry is important not only to diagnose COPD,
but also to assist in treatment to improve patient safety and subsequently reduce costs.
COPD is a very common disease that impacts not only morbidity and mortality, but also
has significant effects on reimbursement rates and hospital readmissions in the United States
(U.S.). In 2010, the amount of both direct and indirect expenses that COPD incurred summated
approximately $50 billion (Guarascio et al., 2013). COPD is also a common cause of
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preventable readmissions to the hospital in the United States (U.S. Department of Health and
Human Services, 2015). If a higher number of patients with COPD was accurately diagnosed
with spirometry, then the number of inaccurately diagnosed “COPD” readmissions would be
indirectly decreased (Spero et al., 2017). The U.S. Centers for Medicare and Medicaid (CMS)
has imposed financial disincentives to hospitals with an “unacceptably” high COPD readmission
rate (CMS, n.d.). Therefore, spirometry may potentially save local hospitals monetary revenue
in COPD reimbursement rates.
Chart audit and Provider Feedback
The purpose of a chart audit is to identify whether certain factors can be improved upon.
Provider feedback refers to giving guidance to the provider on ways to improve the area being
audited. Evidence within the literature identifies the chart audit and feedback method as
successful in improving healthcare provider performance measures with compliance to
guidelines (Ivers et al., 2012). One such manuscript by Ospina et al., 2017 intended to review
the success of COPD discharge care bundles, in which documenting spirometry was a
component. The chart audit and feedback method was one strategy utilized, which ultimately
resulted in reduced readmission rates (Ospina et al., 2017). In a chart audit and provider
feedback study, McClellan et al (2003) identified that a chart feedback and education method
regarding A1C levels resulted in improved treatment for diabetic Medicare patients. This chart
audit and feedback method was similarly utilized to educate primary care providers on the need
for spirometry to confirm a COPD diagnosis. Hence, a chart audit and feedback system has been
proven through various studies to be an effective intervention to improve provider compliance
and was used in this project to improve provider compliance with ordering spirometry.
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Problem Statement
Despite the 2017 GOLD guidelines and a plethora of other quality literature,
approximately 30% of patients are misdiagnosed with COPD due to a lack of utilization of
spirometry in the primary care setting (Walters et al., 2011). The 2017 GOLD guidelines
recommend utilizing spirometry to confirm the diagnosis of COPD. Utilizing spirometry for
COPD diagnosis has been shown to reduce COPD misdiagnoses, assist in cost saving
approaches, reduce the considerable burden COPD has on the healthcare system, prevent COPD
readmissions, and improve quality of life/outcomes.
Purpose of the Project
The purpose of this scholarly project is to implement a chart audit and feedback method
aimed at educating primary care providers to increase the appropriate ordering of spirometry.
Utilizing a chart audit and feedback method has been shown to be successful in improving
healthcare provider compliance with evidenced-based practice guidelines (Ivers et al., 2012).
Clinical Question
Does a chart audit and feedback method improve the number of primary care providers
who appropriately order spirometry to confirm the diagnosis of COPD?
Population: Primary care providers.
Intervention: Chart audit and educational feedback.
Comparison: Standard practice.
Outcomes: Increase appropriate use of spirometry to confirm the COPD diagnosis.
Literature Review and Synthesis
A comprehensive electronic database search was completed using ProQuest, CINAHL,
and the Cochrane Library. Search terms included spirometry, COPD, gold standard, providers,
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quality of care, chart audit and feedback. No limits were placed on the type of article or
published date. The search was limited to the English language with full text. A total of
approximately 800 articles with published dates ranging from 2001 to 2017 were identified.
Narrowing down the search based on the quality of the literature, relevance, published date, and
type of study, ultimately yielded 21 articles for the literature review.
Quality Critical Appraisal
A single reviewer examined the quality of each study and the guidelines were appraised
according to the Appraisal of Guidelines Research & Evaluation II tool (AGREE, 2013). The
systematic reviews and other clinical trials were appraised according to the Scottish
Intercollegiate Guidelines Network (SIGN, 2015). The team leader examined each article for the
level of evidence according to Melnyk’s system of hierarchy (University of Michigan Library,
2015). The quality of each study is provided in Appendix A.
Systematic Reviews
A strong systematic review of randomized controlled trials reveals the impact audit and
feedback has on healthcare professionals practice and patient outcomes (Ivers et al., 2012). In
addition, the purpose of the systematic review was to examine some causes of the differences
between the effectiveness of various audit and feedback opportunities (Ivers et al., 2012).
The systematic review analyzed 140 randomized controlled trials, and only trials which
utilized the audit and feedback system as a core component of their intervention were considered
as part of the systematic review (Ivers et al., 2012). Two independent reviewers examined these
trials after eliminating trials with a considerably high risk of bias, 82 comparisons from 49
studies, and those displaying dichotomous outcomes (Ivers et al., 2012). The weighted median
adjusted risk difference (RD) was a 4.3% increase in healthcare providers’ compliance with an
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interquartile range of 0.5% to 16% absolute increase after utilizing audit and feedback (Ivers et
al., 2012). Multivariable meta-regression determined feedback is more effective when the prior
performance level is considered low, when the feedback was presented by a supervisor or
colleague, when the feedback is presented more than once, if it is presented in verbal and written
methods, and when it incorporates explicit targets and an action plan (Ivers et al., 2012). Finally,
the magnitude of impact was altered by the clinical behavior designed by the intervention (Ivers
et al., 2012).
The main strength of this systematic review was the large sample size of 140 randomized
controlled trials that were analyzed and the RD being 4.3% (Ivers et al., 2012). Another strength
of this systematic review was the utilization of two independent authors, who initially reviewed
the literature and further screened the articles according to the inclusion criteria (Ivers et al.,
2012). Two weaknesses identified from this review were eliminating studies which did not
contain baseline calculations and limiting the examination for certain factors based on practical
use of abstracts (Ivers et al., 2012).
Ospina et al., 2017 organized a systematic review regarding the validity of utilizing
COPD discharge care bundles when patients with COPD are discharged from the hospital. An
information specialist conducted an electronic database search, which was based on specific
search criteria including COPD and discharge care bundles, in which documenting spirometry is
a component (Ospina et al., 2017). Two independent examiners reviewed the results and
identified 5,863 studies. A total of 14 different studies in 21 publications were included in the
systematic review after removing duplicate studies, excluding records, excluding articles for
other indications such as the bundle not being conducted at discharge, and removing multiple
publications (Ospina et al., 2017). Of the 14 studies, five were clinical trials, seven were
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uncontrolled trials, and two were interrupted time series (Ospina et al., 2017). A random effects
meta-analyses was performed of the clinical trials for readmission, mortality, and quality of life
(Ospina et al., 2017).
Ospina et al., examined a total of 14 studies with 26 different elements of care. Four
main trials revealed that these bundles reduced readmissions to the hospital, one of which
included documenting spirometry. One of the strategies identified in implementing this bundle
was the chart audit and feedback. Four of the clinical trials with moderate to high bias revealed
that COPD discharge bundles lowered hospital readmissions with a pooled risk ratio of 0.80 with
a 95% confidence interval and ranging from 0.65 to 0.99 (Ospina et al., 2017). Although
insufficient data was not able to reveal whether COPD discharge care bundles had a significant
impact on long-term mortality or quality of life, the bundles likely reduced COPD exacerbated
readmissions (Ospina et al., 2017). The systematic review aspect of this manuscript was a major
strength as well as its utilization of a meta-analysis (Ospina et al., 2017). One weakness is the
resulting smaller sample size being 14 studies and possible bias due to a lack of similarity and
blinding (Ospina et al., 2017).
Clinical Practice Guidelines
Global Initiative for Chronic Obstructive Lung Disease. The Global Initiative for
Chronic Obstructive Lung Disease (GOLD) 2017 guideline is a worldwide “strategy document”
with the purpose to assist health care providers in diagnosing, managing, and preventing COPD
(GOLD, 2017). The GOLD program was initiated in 1998 and was developed to provide the
best scientific information. The first GOLD guideline was available in 2001. Revisions have
been made over the years with 2017 being the most recent version. The purpose of the 2017
report was to provide a non-biased, well-researched review of the provided evidence for
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assessing, diagnosing, and treating patients with COPD. A PubMed search was utilized by the
GOLD science committee. Search fields included: COPD, all-fields, adult, at least 19 years old,
abstracts included, analyses, clinical trial, and human. The literature update for this edition was
published between 2015 and 2016. The revised guidelines were distributed to 10 experts
externally from the GOLD members. The guidelines were revised based on these experts’
recommendations.
The levels of evidence were designated to certain recommendations and ranged from A to
D. A were those randomized controlled trials with at least two trials with a large sample size. B
also consisted of randomized controlled trials, but with some limitations such as a smaller
sample size or flaws. C indicated nonrandomized controlled trials or observational studies. D
were opinions of a panel. According to the GOLD guidelines, one significant recommendation
was provided which is valuable to this project; spirometry is necessary to confirm the diagnosis
of COPD. Spirometry continues to be vital in the diagnosis, determining the prognosis and
nonpharmacological treatment of COPD. Spirometry is the most objective and reproducible way
to determine airflow limitation. It is noninvasive and readily available in many areas.
Spirometry should be utilized to assist in the confirmation process for the diagnosis of COPD.
One strength of this guideline is its expert committee members, who are known leaders
with expert research and clinical experience with COPD. Two independent committee members
analyzed each abstract and recommendations made by these reviewers were discussed by the
committee biannually. One weakness of this guideline is the lack of documentation of the
number of abstracts reviewed for the 2017 revision.
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Randomized Controlled Trials
McClellan et al., 2003 developed a randomized controlled trial, with the purpose of
determining whether an intervention involving a chart audit and feedback of hemoglobin A1C
would cause more frequent monitoring. Patients who met the diabetes criteria for the study were
assigned to a randomized trial of randomly selected physicians in a southern American state
(McClellan, Millman, Presley, Couzins, & Flanders, 2003). The patient sample was about
23,000 people and the physicians were about 477 in 123 counties (McClellan et al., 2003). After
assigning patients to physicians, each county was placed in alphabetical order and randomly
assigned a number, which was used to assign to either the intervention or control group
(McClellan et al., 2003). The intervention utilized a claims-based feedback (McClellan et al.,
2003). The researcher found that rates for the quality indicators increased as well as the rate of
A1C testing from 13.0% to 16.8% (McClellan et al, 2003). Therefore, chart audit feedback with
education regarding A1C levels resulted in improved treatment for diabetic Medicare patients
(McClellan et al., 2003). This quality research study reveals the successful nature of chart audit
and feedback, which is significant to this project. The strength of this study was the randomized
aspect as well as the large sample size (23,000 patients, 477 physicians, 123 counties)
(McClellan et al., 2003). Limitations include a possible over or underestimation, since indicators
were initially assigned to the patients and then the providers (McClellan et al., 2003). Another
limitation is that the study occurred only within rural counties in a single state.
Thomas et al., 2007 conducted a randomized controlled trial with the purpose to examine
the impact an audit, feedback, and patient reminder system would have on diabetes care. The
randomized controlled trial incorporated a total of 78 subjects to which 39 residents received the
instructions, chart audit, feedback, and letter (Thomas et al., 2007). Another 39 were in the
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control group (Thomas et al., 2007). Patients that were treated by the intervention group had an
improved adherence to the A1C recommendations compared to the control group (Thomas et al.,
2007). Therefore, using a chart audit and feedback system with providers improved diabetes
care processes, although it did not necessarily impact the intermediate clinical results (Thomas et
al., 2007). The RCT aspect of this study was a major strength. The inability to have binding
because of the intervention was a limitation to this study (Thomas et al., 2007).
A total of 1,236 subjects who were diagnosed with COPD were included in one
randomized controlled study (Guerriero et al., 2015). The aim of this study was to evaluate the
prevalence of COPD in Northern Italy utilizing the GOLD and ERS/ATS criteria (Guerriero et
al., 2015). This randomized controlled study sent 5,000 invitation letters and 1,236 subjects
were included based on reply and ability to perform spirometry (Guerriero et al., 2015). The
study utilized spirometry and physician assessment (Guerriero et al., 2015). A total of 26.7% of
subjects experienced daily pulmonary symptoms and only 30.7% had previously received
spirometry (Guerriero et al., 2015). The COPD prevalence depended on the criteria utilized:
11.7% with the GOLD criteria, 9.1% LLN, and 6.8% physician diagnosis (Guerriero et al.,
2015). Of the subjects previously diagnosed, 48.8% never received spirometry (Guerriero et al.,
2015). Based on the prevalence of patients with COPD, an underdiagnosis/misdiagnosis of
COPD occurs if spirometry was underutilized (Guerriero et al., 2015). This may affect quality of
life and fiscal means, that may be preventable if spirometry were utilized (Guerriero et al., 2015).
The random aspect of this study is one main strength as well as the population size (Guerriero et
al., 2015). Also, the study utilized different criterion, which was more thorough. One limitation
was that the prevalence studied was confined to one specific area, which could limit the
generalizability.
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Quasi-experimental Trials
Walters et al., 2011 was a cross-sectional quasi-experimental trial, which was conducted
with the purpose of quantifying the number of patients with COPD who were misclassified in
primary care, and to identify the causes correlated with the misdiagnoses (Walters et al., 2011).
A cross-sectional study was completed in 31 different practices in Australia (Walters et al.,
2011). A total of 341 patients were eligible for the study based on their COPD diagnosis or
prescription for Tiotropium (Walters et al., 2011). The subjects were given spirometry testing
and the results concluded that of the 341 patients with a COPD diagnosis/Tiotropium usage, 107
were misclassified (Walters et al., 2011). Misclassification was shown to be increased with
overweight/obese patients and those that have reported allergic rhinitis (Walters et al., 2011).
Basing a COPD diagnosis on symptoms in primary care may be inaccurate, especially with
overweight patients (Walters et al., 2011). The study highlighted the importance of utilizing
spirometry to prevent improper management (Walters et al., 2011). One strength of this study
was that the intervention occurred across many different practices (Walters et al., 2011). A main
limitation was that the study examined patients with COPD in primary care only, and not an
ambulatory setting (Walters et al., 2011).
One study examined if gender bias affected the diagnosis of COPD (Chapman, Tashkin,
& Pye, 2001). A random sample of 192 primary care physicians completed a hypothetical case
study and follow-up interview (Chapman et al., 2001). A hypothetical case study and interview
was provided to the PCP’s and the outcome revealed that COPD was a more likely diagnosis to
be given to a male by 16% (Chapman et al., 2001). Primary care physicians underdiagnose
COPD, especially with their female patients (Chapman et al., 2001). Spirometry is underused
and may ultimately reduce COPD under diagnosis along with gender bias (Chapman et al.,
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2001). The random sampling method of selecting physicians was a strength (Chapman et al.,
2001). A limitation included the lack of studying real encounters with patients, and the
physicians background/training was not examined (Chapman et al., 2001).
Other Evidence
13 other articles were analyzed for quality of data to provide further evidence for the
need to use spirometry to confirm the diagnosis of COPD. Each article had its own strengths and
purpose and most limitations were related to having a lower level of evidence.
Synthesis
Misdiagnosed COPD. Utilizing spirometry to confirm the diagnosis of chronic
obstructive pulmonary disease (COPD) in the primary care setting is vital. When a spirometry is
not utilized in diagnosing COPD, inaccurate diagnoses are common. One study utilized a crosssectional investigation to examine 341 patients in Australia who had a COPD diagnosis or were
prescribed tiotropium with a general practitioner recognition (Walters et al., 2011). Of the 341
patients who were given spirometry, it was found that 31% (107) had been misclassified with
COPD (Walters et al., 2011). This study recognized the importance of using spirometry to
diagnose COPD and also highlighted the unreliable nature of diagnosing a patient with COPD
based on reported symptoms alone (Walters et al., 2011).
Spirometry also assists in avoiding a delay in treatment by not misdiagnosing COPD.
Jagana, 2015, examined the cause of the delays in treating COPD (Jagana, Bartter, & Joshi,
2015). The study concluded that underutilizing spirometry in primary care was linked to COPD
misdiagnosis (Jagana et al., 2015). One interesting point discussed was that although the use of
spirometry was available to 52% of subjects, only 31% actually utilized spirometry to confirm all
of their COPD diagnoses and provide timely and appropriate treatment (Jagana et al., 2015).
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Therefore, it is important to educate providers on the importance of utilizing the gold standard of
spirometry to diagnose and not misdiagnose COPD (Jagana et al., 2015). This study is of
significant interest to this project because the main intervention of the project will be to educate
primary care providers in the office setting to increase the usage of spirometry as the gold
standard in diagnosing COPD. This mirrors the Jagana study, which was to reduce the delay in
diagnosing and treating COPD in primary care (Jagana et al., 2015).
COPD is not only unreliably diagnosed based on symptoms, but it is also often
underdiagnosed based on patient identifying factors, such as gender. One particular study
examined 192 primary care physicians, to identify whether there was a correlation between
diagnosing COPD and gender bias (Chapman, Tashkin, & Pye, 2001). The study used a sample
of primary care physicians and concluded that these providers were more likely to diagnose a
male patient with COPD than a female (Chapman, Tashkin, & Pye, 2001). The article also
concluded that initially, only 22% of these physicians were likely to utilize spirometry to
diagnose COPD (Chapman, Tashkin, & Pye, 2001). Again the need for spirometry was
confirmed in order to assist in a reliable diagnosis of COPD, but also to assist in avoiding
identifying factors such as gender bias when diagnosing COPD.
Gender bias is not the only identifying factor that is associated with the lack of
spirometry. One study examined the correlation of patient and physician factors when ordering
spirometry to confirm the diagnosis of COPD (Gershon, Hwee, Croxford, Aaron, & To, 2014).
The population study examined 491,754 patients in Ontario, Canada (Gershon, et al., 2014). It
was concluded that only 35.9% of these patients who were newly diagnosed with COPD ever
received a spirometry test (Gershon, 2014). Therefore, spirometry is still underutilized in many
areas, including Canada. The article also highlighted a correlation between patient age,
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comorbidity, and physician factors with the use of spirometry (Gershon, 2014). Regardless of
the factors associated with the lack of spirometry usage, it is clear that primary care providers
need to increase their usage of spirometry to diagnose COPD.
The need for spirometry avoids empirically diagnosing or treating patients with COPD
while concurrently misdiagnosing these patients. One study examined patient safety concerns
when providers empirically diagnose and treat patients regardless of spirometry results (Fortis,
Corazalla, Jacobs, & Kim, 2016). The article concluded that although only 7% of patients were
empirically diagnosed with COPD, 82% of these patients were also empirically treated (Fortis et
al., 2016). The study highlighted the importance of primary care providers avoiding this
improper treatment as it increases unnecessary costs of treatment as well as possibly resulting in
avoidable adverse reactions (Fortis et al., 2016). Therefore, although this project is attempting to
increase spirometry, it is still important to consider that some providers may continue to
empirically treat patients regardless of their spirometry results.
Avoiding misdiagnosing patients with COPD by utilizing spirometry, especially on those
patients who are frequent exacerbators, is necessary. One study was unique in that it explored
the misclassifications among COPD and asthma patients that are prone to having frequent
exacerbations (Jain et al., 2015). 333 patients were selected, who have had frequent
exacerbations of either asthma or COPD and a retrospective chart review ensued (Jain et al.,
2015). The article concluded that objectively confirming airway obstruction, especially among
those with frequent exacerbations, was necessary compared to clinically diagnosing patients
based on symptoms (Jain et al., 2015). Spirometry was shown to greatly reduce the risk of
misdiagnosing COPD or asthma (Jain et al., 2015). This article further highlights the vital
importance of confirming a COPD diagnosis with objective testing, such as with spirometry.
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Another study was conducted in Latin America that examined the degree to which COPD was
under or misdiagnosed in the primary care setting (Casas Herrera et al., 2016). The article
confirmed the need for spirometry to be increasingly utilized in primary care to avoid
underdiagnosing and misdiagnosing COPD (Casas Herrera et al., 2016).
Spirometry is also necessary because a high percentage of patients are over diagnosed
with COPD based on lack of use of spirometry. One study examined the frequency of COPD
overdiagnosis among underserved patients with a government qualified organization (Ghattas,
Dai, Gemmel, & Awad, 2013). A descriptive retrospective cohort study included 80 patients
who were either previously diagnosed with COPD or receiving anticholinergic inhalers without a
COPD diagnosis (Ghattas et al., 2013). These patients were given spirometry testing and
concluded that about 42.5% of these patients had no obstruction and 22.5% had a reversible form
of obstruction (Ghattas et al., 2013). Therefore, a high percentage of these underserved patients
who were either treated for COPD or diagnosed as COPD did not objectively have COPD based
on spirometry (Ghattas et al., 2013). This study is helpful for this project, as it provides further
evidence of the importance of ordering spirometry to confirm the diagnosis of COPD.
Spirometry also needs to be performed before patients are misdiagnosed with COPD,
and/or admitted/readmitted. Spero, 2017, examined the frequency of COPD overdiagnosis, but
specifically analyzed patients in the hospital setting (Spero, Bayasi, Beaudry, Barber, & Khorfan,
2017). The purpose of the study was to examine the percentage of hospital COPD patients that
received confirmatory testing with spirometry and to examine the accuracy of the diagnosis
(Spero et al., 2017). The study examined 6,018 patients with COPD in the hospital, of which
504 had completed spirometry during their hospital stay (Spero et al., 2017). Of the 504
subjects, COPD was confirmed in 69.2%, 26.6% had a restrictive lung disease, and 4.2% had
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normal spirometry (Spero et al., 2017). One strength of this study was that it was conducted at a
teaching hospital, which reflecting real-life scenarios with COPD (Spero et al., 2017). This
study highlights the necessity to diagnose COPD patients with spirometry in the primary care
office setting before they become admitted and treated inaccurately due to a lack of objective
COPD confirmation (Spero et al., 2017).
Appropriate use of Spirometry. Utilizing spirometry appropriately avoids the
discharged patients from becoming “readmitted” incorrectly with COPD, which is of interest as
it impacts cost savings and the considerable burden COPD has on the global healthcare system.
Without spirometric confirmation of COPD, hospitalizations, readmissions, and utilization of
COPD resources will be wasted. One study examined patient safety concerns when providers
applied the discharge diagnosis of COPD when spirometry was not utilized to confirm the
diagnosis (Wu, Wise, & Medinger, 2017). The study examined 826 patients in the Veterans
Affairs (VA) health system after discharge with a COPD diagnosis (Wu, et al., 2017). About
21% of these patients had no spirometry measurements documented (Wu et al., 2017). The study
emphasized the need for providers to take caution when patients are discharged with a diagnosis
of COPD, mainly if they had not received spirometry (Wu et al., 2017). Without spirometric
confirmation of COPD, COPD hospitalizations, COPD readmissions, and utilization of COPD
resources will be wasted (Wu et al., 2017). For example, if a COPD diagnosis is not confirmed
with spirometry, they may become inaccurately readmitted with COPD negatively impacting
cost savings for the hospital and placing a burden on the global health care system.
Appropriately utilizing spirometry avoids the underdiagnosis of COPD and helps identify
those patients with COPD to allow for proper treatment and improve the quality of care
provided. One study examined the need for primary care providers to increase their usage of
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spirometry to diagnose COPD (Mapel, Dalal, Johnson, Becker, & Hunter, 2015). A multicenter,
cross-sectional, observational study examined patients with COPD and estimated the physicians’
impressions and severity of the patient’s COPD (Mapel et al., 2015). After completion of
spirometry, the results concluded that without ordering spirometry, the primary care physicians
were underestimating the disease severity of their patients with COPD (Mapel et al., 2015). This
negatively impacted quality of care provided for these patients (Mapel et al., 2015). The use of
spirometry for these patients changed the physician’s impressions of the severity of the disease
for about one-third of these patients, further demonstrating the beneficial use of spirometry in
diagnosing and treating patients with COPD (Mapel et al., 2015).
Lacking spirometry usage negatively impacts cost and quality of life issues. A
randomized cross-sectional study examined 1,236 subjects who were diagnosed with COPD
(Guerriero et al., 2015). Only approximately 48.8% of patients had completed spirometry prior
to the initiation of the study (Guerriero et al., 2015). The lack of spirometry use was associated
with COPD misdiagnosis and especially underdiagnosis of COPD, which both lead to quality of
life concerns as well as fiscal irresponsibility (Guerriero et al., 2015). Since COPD is a
progressive disease, to slow the progression one must diagnose promptly, and properly treat this
disease (Guerriero et al., 2015). Hence, mis/underdiagnosing COPD may lead to a lack of work
and social quality of life (Guerriero et al., 2015). The direct and indirect costs of treating COPD
in stage one or two compared to severe COPD is a difference of about twice the cost (Guerriero
et al., 2015). Therefore, by diagnosing COPD early with spirometry, a cost savings can be
recognized (Guerriero et al., 2015).
Improved outcomes with appropriate spirometry usage. Appropriately utilizing
spirometry improves quality of life, patient safety, and cost savings. One study examined 68,898
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patients who were diagnosed with COPD and discovered an interesting correlation (Gershon, et
al., 2017). Confirming the diagnoses of COPD utilizing spirometry is correlated with a
decreased risk of mortality as well as admissions to the hospital for COPD (Gershon et al.,
2017). This study utilized a longitudinal population analysis between 2005 and 2012 (Gershon
et al., 2017). Although some bias and confounding factors may have been identified, this study
highlights the importance of improving quality of care and patient safety by confirming a
diagnosis of COPD with spirometry (Gershon et al., 2017).
Adhering to GOLD standards increases quality of life and provides cost savings. One
particular study investigated the clinical as well as cost saving benefits that resulted from
adhering to the Global Initiative for Chronic Obstructive Lung Disease (GOLD)
recommendations (Asche et al., 2012). A retrospective cohort study design examined 364
subjects and concluded that adhering to the GOLD recommendations not only had clinical
benefits, but also provided cost savings (Asche et al., 2012). This study is relevant to this project
because it confirms evidence that staging COPD with spirometry as well as adhering to the
GOLD recommendations not only increases quality of care, but also provides benefits with cost
savings (Asche et al., 2012).
Improved outcomes with appropriate spirometry usage allows for proper treatment of
those patients with COPD. Walker, 2006 validated the need for spirometry to confirm a COPD
diagnosis specifically in the primary care setting (Walker, Mitchell, Diamantea, Warburton, &
Davies, 2006). The study utilized a retrospective method to analyze if the use of spirometry in
primary care ultimately increased the number of patients diagnosed with COPD (Walker et al.,
2006). The study examined 1,508 subjects that were referred for spirometry, for which 235
patients had post-bronchodilator obstruction (Walker et al., 2006). Of the 235 patients, 130 of
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them received a new diagnosis, mainly COPD (Walker et al., 2006). The study concluded that a
large portion of patients were undertreated before being referred for spirometry (Walker et al.,
2006). Also, the use of spirometry increased the number of COPD patients who received proper
treatment (Walker et al., 2006).
Chart audit and provider feedback. Evidence from one strong systematic review (Ivers
et al., 2012), one moderate systematic review (Ospina et al., 2017), one strong randomized
controlled trial (McClellan et al., 2003), and one moderate randomized controlled trial (Thomas
et al., 2007) supports the use of chart audit and feedback focused on improving provider
adherence with confirming a COPD diagnosis with spirometry.
Ivers et al., 2012 identified chart audit and feedback as a successful method of improving
healthcare provider compliance with evidenced-based practice. Ospina et al., 2017 intended to
review the success of COPD discharge care bundles, in which documenting spirometry is a
component. One strategy utilized was the chart audit and feedback method, which ultimately
resulted in reduced readmission rates (Ospina et al., 2017). Just as the chart audit and feedback
system aided in improved results, an audit and feedback system was utilized in this project to
improve provider compliance with ordering spirometry. McClellan et al., 2003 identified a chart
feedback and education, regarding A1C levels, resulted in improved treatment for diabetic
Medicare patients. This chart audit and feedback method can similarly be utilized to educate
primary care providers on the need for spirometry to confirm a COPD diagnosis. Thomas et al.,
2007 examined the impact a chart audit, feedback system, and patient reminder had on diabetes
care. The audit and feedback ultimately improved diabetes care processes (Thomas et al., 2007).
Hence, a chart audit and feedback system has been proven through various studies to be an
effective intervention to improve provider compliance.
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Conceptual Framework
The conceptual framework utilized for this scholarly project is the Iowa model. The
Iowa model was designed to assist clinicians in the evidenced-based practice (EBP) process to
pursue a methodical approach in conducting and establishing an intended project (Iowa Model
Collaborative, 2017). The six main components of the Iowa model are: identifying a trigger,
determining organizational priority, formulating a team, examining the evidence, implementing
the change into practice, and analyzing the outcomes (Iowa Model Collaborative, 2017).
Permission was provided by the University of Iowa, Department of Nursing to utilize the Iowa
Model to initiate quality improvement for this scholarly project (Appendix C).
Identifying the trigger. Identifying the trigger is the first step in promoting evidencedbased practice (Iowa Model Collaborative, 2017). Triggers may be problem or knowledge
focused (Iowa Model Collaborative, 2017). In this project, the problem focused trigger focuses
on the idea that despite the 2017 GOLD guidelines and a plethora of other quality literature,
approximately 30% of patients are misdiagnosed with COPD due to a lack of utilization of
spirometry in the primary care setting.
Organizational priority. The next step in the Iowa model is to decide if the topic is a
priority (Iowa Model Collaborative, 2017). As discussed in the literature review, a lack of
spirometry usage to confirm COPD diagnosis has many negative ramifications. These include
insufficient quality of care, patient safety concerns, fiscal irresponsibility of the provider, and it
causes a poor reflection on the organization.
It is vital for this scholarly project to align with the mission and values of the
organizational site. If a gap exists between the project purpose/design and the organization, then
the project must be re-formatted. The organizational site determined for this scholarly project is
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a primary care site in the state of Virginia. Both the mission and vision of the site align closely
with the intended scholarly project. Focusing on quality care, while encouraging evidencedbased practice through excellence, is foundational to the implementation of this scholarly project.
Formulating a team. The next step in the Iowa model is to formulate a team and
seamlessly collaborate through teamwork (Iowa Model Collaborative, 2017). Teamwork is
necessary to implement an evidenced-based practice change to proficiently provide the quality
improvement needs. The team members include the team leader who organized the project,
implemented the educational feedback method, and completed the chart audits. The committee
chair provided mentorship, guidance, and feedback with the on-going process. Also, a
measurement consultant formulated and analyzed statistical results.
Examine the evidence. The next step in the Iowa model is to examine the evidence
(Iowa Model Collaborative, 2017). An extensive literature review process occurred and was
reviewed by the project chair. The evidence has also been discussed with administration of the
organizational site and will continue to be shared with the various team members as well as the
providers who are to receive the educational intervention.
Implement the change into practice. The next step in the Iowa Model is to develop and
pilot the practice change of educating primary care providers on the importance of ordering
spirometry to confirm a COPD diagnosis (Iowa Model Collaborative, 2017). Ivers et al., 2012
identified chart audit and feedback as a successful method of improving healthcare provider
compliance with evidenced-based practice. Providing regular feedback to providers regarding
their adherence to the GOLD guidelines is essential in providing quality care.
The pre-intervention process was established through completing a chart audit that
identified patients with a primary or secondary diagnosis of COPD who visited the primary care
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office within the last 30 days. This was the baseline chart audit and required a measurement of
the patients diagnosed with COPD who had spirometry as well as the number of patients
diagnosed with COPD who never had spirometry completed. The intervention portion was
planned and conducted, which was an educational presentation delivered to the providers in the
primary care office setting on the importance and benefits of ordering spirometry to confirm the
diagnosis of COPD. The presentation highlighted the average percentage of patients that are
often misdiagnosed without using spirometry and the GOLD standard of ordering spirometry to
confirm the diagnosis of COPD. A survey was given to the providers before and after the
presentation. Another designing and implementation step was to provide a handout in the office
setting to encourage the providers to continue to order spirometry prior to diagnosing COPD.
Analyze outcomes. The last main step was to implement the evaluation plan, which
involved a post-intervention chart audit. A 30-day and 30 to 60-day post intervention chart audit
was conducted. The rationale is that much improvement may not be seen at the 30-day, but may
at the 60-day audit. If only one audit occurred, and there was no improvement at the 30-day, but
there was improvement at the 60-day, an average of both the 30 and 60-day post intervention
may be negatively skewed. The chart audit examined the number of patients diagnosed with
COPD who had spirometry or were referred for spirometry as well as the number of patients
diagnosed with COPD who did not have a spirometry referral.
Once the implementation process was completed, a determination of whether the change
would be appropriate for adoption in the primary care setting needed to occur (Iowa Model
Collaborative, 2017). A sustainable method for the project would be to focus on engaging
specific staff personnel, such as administration, nurses, and providers, to continue to follow the
GOLD recommendations with ordering spirometry. This could be done by keeping visual
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reminders in the office setting, such as small posters or notices (GOLD, 2017). Also, another
chart audit in the future could continue to measure the impact the presentation and reminders had
on increasing spirometry in the primary care office site as time elapses.
The final step in the Iowa model is to disseminate the results (Iowa Model Collaborative,
2017). Dissemination will occur by discussing the results of this project with key stakeholders
including the Medical Director and other providers with the primary care site. Conducting
another presentation to discuss the results of the post chart audit would be beneficial for the
providers in the office site to illustrate the benefits of the project and identify further inquiry
needs. Publishing the results in a journal as well as creating a poster for appropriate conferences
to improve the number of COPD patients who are diagnosed with spirometry confirmation is
another planned component of the dissemination plan.
Summary
The purpose of this literature review was to identify the clinical problem, identify a
successful intervention, provide beneficial goals and objectives, and provide outcome
measurements. The critical appraisal of data provides strong evidence with apparent quality.
The strong systematic review (Ivers et al., 2012) provides evidence of the success a chart review
and feedback has on provider compliance with evidenced-based practice. The GOLD guidelines
recommend utilizing spirometry to confirm the diagnosis of COPD. Utilizing spirometry to
confirm the diagnosis of COPD assists in preventing misdiagnoses, avoids “readmissions” with
COPD, improves outcomes and patient safety concerns, improves quality of life, is fiscally
beneficial, and reduces the global burden COPD has on our health care system. This literature
review supports the need for this project, which is to increase the number of COPD patients
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diagnosed with spirometry by utilizing a chart audit and feedback system with primary care
providers.
Methodology
Design
The purpose of this scholarly project was to implement a chart audit and feedback
method aimed at educating primary care providers to increase the ordering of spirometry to
confirm the diagnosis of COPD. The goal of this project was to promote an EBP change in
primary care to improve the quality of care provided. The project design was conducted based
on evidence and structure of the Iowa model. The trigger and organizational priority have been
identified and a team has been formulated. The team members include the team leader, the
committee chair, assistance from the measurement consultant, and support from various
administration.
The team leader audited charts for a total of 150 patients with COPD as one of their
diagnoses. These patients must have had visited the primary care office in the last 30 days and
charts were scanned for spirometry. This was completed prior to the educational intervention.
An aggregate group performance data was measured and provided to the participants during the
educational piece. During the educational feedback method, the providers were educated on the
2017 GOLD guidelines, focusing on the recommendations of the importance of appropriately
ordering spirometry to confirm the diagnosis of COPD. Before and after the educational
intervention, a survey was provided to examine if the behavior intention of the providers had
changed. Two handouts were given after the educational intervention to the providers in the
office. A 30-day and 30 to 60-day post intervention chart audit was subsequently completed to
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examine whether an increased number of patients diagnosed with COPD received an order for
spirometry.
Measurable Outcomes
1. After completion of the educational feedback, providers in a primary care setting will
demonstrate a behavior intention change of the guidelines for ordering spirometry to
confirm the diagnosis of COPD. This will be evidenced by an increased average in
the Likert score for all four questions.
2. After completion of the chart audit and feedback method, providers in a primary care
setting will improve their usage of EBP guidelines as evidenced by an increase
number of documented spirometry to confirm the diagnosis of COPD.
Setting, Population, Sample
A primary care office setting in Virginia was chosen as the site for the prospective
scholarly project. The office providers include physicians, nurse practitioners (NP’s), and
physician assistants (PA’s). The Medical Director of the organization has provided a letter of
support for the site (Appendix F). The sample comprises of two different populations: (1)
primary care providers (physicians, nurse practitioners, and physician assistants), (2) adult
patients with COPD as one of their diagnoses.
The inclusion criteria for the first population includes physicians, NP’s, and PA’s
practicing in the primary care setting. The exclusion criteria for the first population includes
non-providers and those who choose not to participate. A total of 6 providers were included in
the project. The inclusion criteria for the second population includes patients with COPD as one
of their diagnoses, age ≥ 18 years old, and <90 years old. The exclusion criteria for the second
population includes patients who do not have COPD as one of their diagnoses, <18 years old, ≥
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90 years old, or under the care of palliative or hospice service. All of the primary care providers
and patients with COPD who meet the inclusion criteria, without exclusion criteria, were
candidates for the scholarly project. However, a cap of 50 patient charts was incorporated for
each audit.
Ethical Considerations
All members of the project team have completed research ethics training to ensure the
protection of human rights. A copy of the Collaborative Institutional Training Initiative (CITI)
certificate is provided in Appendix B. A submission of the final project to the Institutional
Review Board (IRB) of the University was approved by the chair. The project was also
submitted to the organization’s IRB for approval as well. Appendix H and I, respectively display
the University’s and the organization’s approvals. The project leader conducted the chart audit.
A total of 50 charts for the pre and 50 for the post intervention audits were examined. A master
code book was created, which contained each charts’ medical record number, date of service,
and the chart identification assigned code. The master code book was created in an Excel
spreadsheet and saved as a password-protected document and saved on a password-protected,
health information and portability accountability act (HIPAA) compliant computer. Deidentified data was kept separate on a password protected computer. Data documented with the
chart audit tool, survey, and data analysis documents was de-identified of any patient and
provider information. The data collector maintained the master code book set as a password
protected document on a password protected HIPAA compliant computer for 3 years after
completion of the scholarly project. No copies will be made of the master code book and it will
be eliminated from the computer after 3 years. No patient or primary care provider identifying
information associated with any presentation or publication of this project will be done.
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Intervention, Tool, Data Collection
A baseline pre-chart audit was conducted through the electronic medical record system at
the organization to identify patients who have COPD as one of their diagnoses and visited the
office within the prior 30 days. Also, any existing spirometry documentation was examined. A
non-random sampling, purposive, method was utilized for this project. The sample size included
up to 50 charts per audit that contained the inclusion without the exclusion criteria. The data was
entered into Microsoft excel and analyzed with the help of a measurement consultant.
An educational feedback method was conducted by the team leader, which reviewed the
objectives, background, benefits, 2017 GOLD guidelines, the problem, aggregate group
performance data, with a main focus on the necessity to confirm the diagnosis with spirometry,
and implications for practice. A survey was provided before and after the educational
intervention to examine if the behavior intention of the providers changed. The survey was
adapted and modified with permission as shown in Appendix D from the article titled Barriers to
Adherence to COPD Guidelines Among Primary Care Providers (Perez, Wisnivesky,
Lurslurchachai, Kleinman, & Kronish, 2012). The survey was utilized in the project to examine
the behavior intention of the providers based on COPD and the GOLD guidelines (Perez et al.,
2012). Completed in writing, the survey only took about 2-4 minutes. The survey was answered
with a Likert scale from 1-5 with 1 being strongly disagree, 3 neutral, and 5 strongly agree
(Appendix G). The scored ranged from 1-5 with the low score of 1 reflecting the provider’s lack
of intention for change and a high score of 5 reflecting an intention for change. A calculated
average for the pre and post-intervention examined if a behavior intention change has occurred.
The data was entered into Microsoft excel and analyzed. After the educational intervention, a
handout was implemented to the primary care providers to remind providers of some of the
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GOLD guidelines, particularly spirometry testing. A 30-day and 30 to 60-day post intervention
chart audit occurred to examine if an increase number of patients diagnosed with COPD received
spirometry ordering.
Timeline of project stages.
Preparation.
Aligning with the Iowa Model, the team leader already identified the problem focused
trigger, determined it was a topic priority for the organization, created a team, formulated
research and reviewed the available literature, and decided there was a sufficient research base.
The following steps were executed based on the proposed timeline:
•

By February 9th: Complete primary defense with chair

•

By February 16th: Submit proposal to University’s IRB

•

By February 27th: Submit proposal and Universities IRB acceptance letter to site’s IRB
Implementation.
Aligning with the Iowa Model, the evidenced-based practice project was implemented

into practice. The following steps were executed based on the proposed timeline:
• By March 30th: Conduct pre-intervention chart audit (Retrospectively from February 28thMarch 28th)
•

March 30th: Conduct educational feedback method with primary care providers in the office,
and survey was provided before and after education.

•

May 2nd: Conduct 30-day post-intervention chart audit (Retrospectively from April 1st-May
1st)

•

June 2nd: Conduct 60-day post-intervention chart audit (Retrospectively from May 1st-June
1st)
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Evaluation.
Aligning with the Iowa Model, the evidenced-based practice project was evaluated. The
following steps are in the process of being executed based on the proposed timeline:
• By June 16th: Post-intervention chart audits analyzed
• By July 16th: The written scholarly project finished editing and sent to the editor
• By July 23rd: Editor will return paper with recommendations
• By August 3rd: Final defense will be conducted with chair
• By August 10th: Final revisions will be made and project posted to the Digital Commons
• By August 10th: Disseminate to key stakeholders
Feasibility Analysis
A feasibility analysis was performed and includes examination of personnel,
resources/technology, and a cost-benefit analysis was completed.
Personnel.
•

Team leader

•

Scholarly project chair

•

Administration/Primary care providers

•

Statistical Consultant

Resources/Technology.
•

Electronic medical record (EMR) system

•

Provider feedback survey

•

Computer

•

Excel

Other.
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Lunch budget

Cost-Benefit Analysis
The cost of this project reflects mainly the budget for lunch and the editor. The benefits
of this project include possible reduced COPD readmissions, improved patient outcomes and
safety concerns, improved quality of life, fiscal benefits, and that it may ultimately help in
reducing the global burden COPD has on the health care system. The cost of this project is
seemingly low, but the benefits as discussed are relatively high. Therefore, the benefits
outweigh the cost of this project.
Evaluation/Data Analysis
Objectives:
1. After completion of the educational feedback, providers in a primary care setting will
demonstrate a behavior change with the guidelines for ordering spirometry to confirm
the diagnosis of COPD. This will be evidenced by an increased average in the Likert
score for all four questions.
2. After completion of the chart audit and feedback method, providers in a primary care
setting will improve their usage of EBP guidelines as evidenced by an increase
number of documented spirometry to confirm the diagnosis of COPD.
Objective 1: Impact behavior intention for primary care providers.
Method and design.
A quasi-experimental, one group pre-test/posttest design was completed to examine the
impact an educational interventional feedback method has had on the behavior intention of
primary care providers with guidelines for ordering spirometry to confirm the diagnosis of
COPD.
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Sample.
The sample comprised of primary care providers (physicians, NP’s, PA’s). A
nonrandom, purposive, convenient sampling is suggested for the primary sample method. A
total of 6 providers were employed at the primary care office. A total of 18 providers in the
office were sent a recruitment email (Appendix E). The inclusion criteria for the first population
includes physicians, NPs, and PAs practicing in the primary care setting. The exclusion criteria
for the first population includes non-providers and those who choose not to participate.
Data Collection/Tool.
The survey is adapted and modified with permission as shown in Appendix D from the
article titled Barriers to Adherence to COPD Guidelines Among Primary Care Providers (Perez
et al., 2012). The survey only took about 2-4 minutes and was completed in writing. The survey
was answered with a Likert scale from 1-5 with 1 being strongly disagree, 3 neutral, and 5
strongly agree. The average was calculated for the pre and post-intervention to examine if the
behavior intention of the providers has changed. During the educational feedback method, the
providers were educated on the 2017 GOLD guidelines, focusing on the recommendations of the
importance of appropriately ordering spirometry to confirm the diagnosis of COPD.
Statistical Analysis.
The dependent variable of interest (provider behavior intention) is presented with a Likert
scale from 1-5 with 1 being strongly disagree, 3 neutral, and 5 strongly agree (Appendix G). The
average was calculated for the pre and post-intervention examining if a behavior intention
change has occurred. The data was entered into Microsoft excel and analyzed. Descriptive
statistics and analysis (mean) was conducted to examine provider behavior intention with the
GOLD guidelines for spirometry ordering (Appendix G).
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Objective 2: Primary care providers will increase the number of documented
spirometry to confirm the diagnosis of COPD.
Method and design.
A quasi-experimental, one group pre-test/posttest design was utilized to examine the
impact a chart audit and educational feedback method has had on the primary care providers’
usage of EBP guidelines as evidenced by an increase number of documented spirometry to
confirm the diagnosis of COPD.
Sample.
The sample populations were adult patients with COPD as one of their diagnoses (J 44).
The inclusion criteria included patients with COPD as one of their diagnoses, age ≥ 18 years old,
and < 90 years old. The exclusion criteria included patients who did not have COPD as their
diagnosis, <18 years old, ≥ 90 years old, or under the care of palliative or hospice service. The
number of patients who met the inclusion criteria for the chart audit was 50 charts per chart
audit. Therefore, a maximum of 50 charts for the pre chart audit, 50 charts for the 30-day post
chart audit, and 50 charts for the 30 to 60-day post chart audit was analyzed.
Data Collection/Tool.
A 30-day retrospective chart review was implemented for pre-intervention information and a
30-day and 60-day post intervention audit. Data collection proceeded as follows:
1. A chart search method for population identification was performed by the assistants and
the project leader reviewed the identified patients for inclusion and exclusion criteria.
a) Searched medical record for patients with COPD as a diagnosis (J 44)
b) Narrow search by visited date range (previous 30-day period)
c) Narrow search by patient age in years (18 years or older)
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d) Narrow search to by patient in years (89 years or younger)
2. The project leader evaluated the chart to examine if spirometry was documented.
The post chart audit was conducted in the same way as the pre chart audit, with the
modification of changing the search visited date range to the previous 30-day and 60-day.
3. A master code book was created, which contained each chart’s medical record number,
date of service, and the chart identification assigned code. The master code book was
created in an Excel spreadsheet and saved as a password-protected document and saved
on a password-protected, health information and portability accountability act (HIPAA)
compliant computer. De-identified data was kept separately on a password protected
computer. Data documented with the chart audit tool, survey, and data analysis
documents was de-identified of any patient and provider information.
4. The data collector will maintain the master code book set as a password protected
document on a password protected HIPAA compliant computer for 3 years after
completion of the scholarly project. No copies will be made of the master code book and
it will be eliminated from the computer after 3 years. No patient or primary care provider
identifying information associated with any presentation or publication of this project
will be done.
Statistical Analysis.
Statistical analysis was conducted in two phases: pre and post intervention. One
statistical method, a statistical z-test, comparing the percentages of each sample was used to
evaluate objective 2. The percentages reflect the number of patients who have had spirometry
documented from the whole sample of COPD patients. This test was used for the pre and post
intervention to compare the number of spirometry tests documented pre and post intervention.
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Results

A total of 18 providers were invited to participate in this scholarly project with 6
providers actually participating who met the inclusion criteria without the exclusion criteria. A
total of 150 charts were audited, with 50 charts for the pre, 50 for the 30-day, and 50 for the 60day post-intervention chart audits. The various demographics of the primary care providers,
sample size, assumptions, significant findings, and a summary of the results is provided.
Demographics
Sample size. A total of 6 providers who participated in this scholarly project (n=6). The
pre and post survey were collected on all 6 providers. The chart audits included a total of 150
(n=150), with 50 being the pre chart, 50 for the 30-day, and 50 for the 60-day post-intervention
audit.
Years of experience. Of the 6 providers who participated, 1 had less than 5 years of
experience, 1 had 5-10 years of experience, 2 had 11-20 years of experience, 2 had greater than
20 years of experience; see figure 1.

Figure 1. Years of Provider's Experience.
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Type of healthcare profession. There was a total of 3 physicians, 2 nurse practitioners,
and one physician assistant who participated in this scholarly project; see figure 2.

Figure 2. Type of Provider Healthcare Profession.
Assumptions
There were two main assumptions made during this scholarly project. The first
assumption was that the participants answered the questions honestly and not as they thought
they should answer the questions. The second assumption was that the providers ordered
spirometry to confirm a COPD diagnosis, rather than for other reasons.
Main Findings
A total of 50 patients diagnosed with COPD who visited the primary care office within
the prior thirty days were included in the pre-chart audit. A total of 50 patients for the 30-day
and 50 patients for the 60-day post-chart audits were included. The pre-chart audit revealed that
27/50 (54%) of patients had previously had spirometry documented to confirm a COPD
diagnosis. Thirty-day post chart audit and feedback intervention 33/50 (66%) and sixty-day post
chart audit and feedback intervention revealed 31/50 (62%) of patients had spirometry
documented to confirm a COPD diagnosis (see table 1 and figure 3).
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Table 1
Documented Spirometry Rate
Stage
Documented Spirometry
Pre-chart Audit

27

30-day Post

33

60-day post

31

Figure 3. Documented Spirometry Rate.
During the three chart audits, spirometry ordering trends were also analyzed based on the
dates that the spirometry tests had been ordered (see table 2 and figure 4). Those ordered less
than 30 days prior revealed an increase from the pre to 30-day and a slight increase from pre to
60-day post-chart audit. The 30-day to 6 months was about the same with a 3, 3, and 2 result.
The 6 months to 1-year period was a 2, 3, 2. The 1 to 2-year period was a 5, 4, 1. Finally,
greater than 2 years was a 17, 18, 24 results. This suggests no obvious spirometry referral trend.
However, further research maybe able to examine for a lengthier and larger sample size trend.
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Table 2
Spirometry Referral Trend
30d-

6m-

1y-

Stage

<30d

6m

1y

2y

>2y

Pre

0

3

2

5

17

30-day post

5

3

3

4

18

60-day post

2

2

2

1

24

Figure 4. Spirometry Referral Trend.
The survey was conducted before and after the providers were educated on the
importance of ordering spirometry to confirm the diagnosis of COPD (Appendix A). The survey
took about 2-4 minutes and was completed by providers in writing. The survey is answered with
a Likert scale from 1-5 with 1 being strongly disagree, 3 neutral, and 5 strongly agree. The
average was calculated for the pre and post-intervention and examined whether a behavioral
intention has occurred. The score reflected behavioral intention; the higher the score, the more
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likely the provider was to order spirometry to confirm a COPD diagnosis. The pre-survey
average totaled 3.17/5. The post survey average totaled 4.33/5. The pre to post-intervention
survey of 6 providers revealed an increase behavior intention from 63.4% to 86.6%, which is a
23.3% increase in behavior intention. Therefore, there is a 23.3% increased likelihood that the
providers will order spirometry to confirm their COPD diagnosis.
Two-proportions Z-test. A two-proportions Z-test was conducted with α = 0.05. The Ztest at 30 days revealed the P-value corresponding to z-1.225 is 0.112. The Z-test from the prechart audit to the 60-day post-chart audit revealed the P-value corresponding to z-0.8104 is
0.2088.
Summary of Results
The outcomes for this scholarly project were measured as follows: (1) increased primary
care provider behavior intention to order spirometry to confirm a COPD diagnosis and (2)
increased number of documented spirometry referrals.
Outcome 1. Increased primary care provider behavior intention to order spirometry
to confirm a COPD diagnosis. As identified by the post survey, the primary care providers
were more likely to order spirometry to confirm the diagnosis of COPD following the
intervention. These results were identified as the average of the pre to post-intervention survey
of 6 providers revealed an increase behavior intention from 63.4% to 86.6%, which is a 23.3%
increase in behavior intention. Therefore, there is a 23.3% increased likelihood that the
providers will order spirometry to confirm their COPD diagnosis.
Outcome 2. Increased number of documented spirometry referrals. As the twoproportions Z-test revealed, which was conducted with α = 0.05, the Z-test at 30 days revealed
the P-value corresponding to z-1.225 is 0.112. The Z-test from the pre-chart audit to the 60-day
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post-chart audit revealed the P-value corresponding to z-0.8104 is 0.2088. Therefore, although
there is not significant statistical evidence for either Z-test, there is a clinically significant
increase in spirometry referrals documented.
Discussion
The purpose of this scholarly project was to determine the effectiveness of using a chart
audit and feedback method to educate primary care providers on confirming COPD diagnosis
with spirometry. The results of this project show that although there is not significant statistical
evidence for either Z-test, there is clinical significance. Despite the fact that the results did not
reveal statistical significance in increasing the number of patients who received spirometry, there
are a number of positive outcomes. The literature review documented a plethora of research,
clinical guidelines, and documented benefits concerning the significance of ordering spirometry
to confirm the diagnosis of COPD. The limitations and clinical implications of this project need
to be considered for any further exploration of the need for spirometry to confirm the diagnosis
of COPD.
Strengths
Strengths of this project include the following: (1) cost effectiveness, (2) multiple
methods of data collection, and (3) the swift rate of collecting data. The cost of this project was
minimal and required no outside fiscal assistance. The multiple methods of data collection
included the surveys as well as the chart audits, thereby yielding a well-rounded project and
reducing bias. Finally, obtaining outcomes in a short time frame assisted in completing and
obtaining results quickly.
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Limitations
Limitations to this project include the following: (1) time, (2) chart sample (3) provider
sample size (4) manual process of locating spirometry results in the charts, and (5) repeat
patients from one audit to another. Auditing charts for only 60 days after the educational
intervention was not long enough to reveal a trend towards increasing spirometry referrals.
Further studies could lengthen the timeline in order to examine for a trend towards ordering
spirometry to confirm a COPD diagnosis. In addition, a larger sample size of audited charts
being only 50 patients is not quite ideal for this project. A larger sample size of both charts and
providers would have more accurately reflected the population of COPD patients and primary
care providers as a whole.
The manual process of locating spirometry results in the charts was a definite limitation.
Because of the amount of information that needed to be manually examined in each chart, it was
possible to miss spirometry documentation. If spirometry were to be succinctly documented in
the medical record, the results would be more definitive. Finally, some patients who visited the
office during the pre-chart audit time frame may have also visited the office during the 30 or 60day post chart audit period. Hence, some results may have been slightly impacted due to this
occurrence. Additional use of electronic medical record analysis may be one solution to this
difficulty.
Implications for Practice
Although there was no statistical significance of this project, one of the purposes was to
increase the awareness of the primary care providers of the importance of ordering spirometry to
confirm the diagnosis of COPD. The results of this scholarly project indicate that there was
clinical significance, as an increase in the number of spirometry ordering and a slight trend
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towards more spirometry ordering can be assumed. Therefore, a chart audit and educational
feedback method is clinically beneficial in assisting providers in the primary care setting to
incorporate spirometry to confirm the diagnosis of COPD. The results also indicate that a chart
audit and feedback method can be utilized in the primary care setting to enact and promote an
evidenced-based practice.
Utilizing spirometry to confirm the diagnosis of COPD is a GOLD guideline and is
considered vital (GOLD, 2017). The multiple benefits can be appreciated including its
assistance in avoiding misdiagnosing COPD, cost saving approaches, and reducing the
considerable burden COPD has on the healthcare system (Walters et al., 2011 & Fortis et al.,
2016). It also helps prevent inaccurate COPD readmissions and improve the patient’s quality of
life/outcomes (Guerriero et al., 2015). These benefits, a plethora of other literature, and the
findings of this EBP project encourage the use of a chart audit and educational intervention
method to promote the use of spirometry to confirm the diagnosis of COPD.
As literature and this project reflect, many primary care providers, including this primary
care site, have not been utilizing spirometry and its multitude of benefits to confirm the diagnosis
of COPD. This problem needs to continue to be addressed in clinical practice in the primary care
setting to promote the benefits and prevent the issues of not utilizing spirometry in this manner.
Since COPD continues to be one of the greater causes of readmissions in the United States
according to the U.S. Centers for Medicare and Medicaid (CMS), the more promptly and
accurately the diagnosis is made, the sooner patient safety and quality of care can be improved
(CMS, n.d.).
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Implications for Research
Further research is recommended to be completed on a greater scale, with a larger sample
size, and longer period of time to more accurately examine whether a chart audit and feedback
method is beneficial in impacting EBP projects such as this project. More research should be
conducted to observe the direct benefits of utilizing spirometry to confirm the diagnosis of
COPD including the fiscal aspect, patient quality of care, and morbidity and mortality rates.
Also, readmissions and a cost savings approach in this manner should be considered and
examined.
More research can also be examined in regards to this particular project as further chart
audits could be completed in 3 months, 6 months, and 1 year to determine if a trend is occurring.
Finally, another survey could be completed to examine whether the primary care site’s providers
could identify benefits or challenges in ordering spirometry according to the GOLD guidelines.
Dissemination plan
The dissemination plan needs to be addressed as this is vital to spread the findings of this
project to the target audience as well as educate providers on the importance of ordering
spirometry to confirm a COPD diagnosis. The goals of the dissemination plan are as follows:
1. Educate primary care providers about the importance of ordering spirometry to confirm
the diagnosis of COPD.
2. Encourage the primary care providers at the site to continue to order spirometry to
confirm their diagnoses of COPD.
3. Educate the public about the benefits of utilizing a chart audit and feedback method to
promote evidenced-based practice.
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4. Educate the public regarding the benefits of ordering spirometry to confirm the diagnosis
of COPD.
The dissemination plan will be conducted by the project leader. The first step of the
dissemination plan is to share the findings with the providers at the primary care site as well
as the medical director. A presentation will be provided over email, which will include bar
graphs and tables to demonstrate the results. Dissemination of the project will also be
planned through a submission of a poster presentation to be presented at a conference in New
York state. This will ultimately have a target audience of clinical professionals including
nurses, nurse practitioners, physician assistants, or physicians. This project will also be
submitted to the Digital Commons to reach a broader audience. Finally, a manuscript
submission to a journal will be completed.
Conclusion
Despite being a GOLD guideline and having documented benefits, confirming a COPD
diagnosis with spirometry is not routinely done in the primary care setting (Walters et al., 2011).
The purpose of this project was to increase referrals for spirometry to confirm COPD diagnosis
and to determine the effectiveness of using a chart audit and feedback method to educate primary
care providers on confirming COPD diagnosis with spirometry. A quasi-experimental design
was incorporated in a primary care office. A retrospective pre-intervention chart audit and two
post-chart audits, at 30 and 60 days compared the frequency of documented spirometry to
confirm a COPD diagnosis. An educational intervention with a pre and post-survey examined
whether the intervention changed provider behavior intention to order spirometry to confirm a
COPD diagnosis. Although there was not a statistically significant increase in the number of
spirometry referrals, there was a clinically significant increase. After implementing a chart audit
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and educational intervention, the provider’s behavior intention also increased. Hence, a chart
audit and educational intervention is helpful to improve primary care provider’s behavior
intention for specific clinical practice guidelines as well as a clinical increase in the evidencedbased practice goal. Further research is necessary to determine if other settings would have
similar results.
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Study Purpose/

Design,

LO

Intervention &

Objective(s)

Sampling

E

Outcomes

Results

Study
Strengths &

Method, &

Limitations

Subjects
Global Initiative

The purpose of

A PubMed

for Chronic

this report is to

Obstructive Lung
Disease (GOLD)
(2017).

Spirometry is

Spirometry

Strengths

search was

necessary to

continues to be

include the

provide non-

utilized by the

diagnose COPD.

the key in

consistent

biased, well-

GOLD

diagnosis,

treatment

researched

science

determining

objectives and

review of the

committee.

prognosis, and

the simplicity of

provided

The search

nonpharmacolog

the COPD

evidence for

fields

ical treatment.

severity

assessing,

included:

classifications.

diagnosing, and

COPD, all-

A study

treating patients

fields, adult,

limitation was

with COPD.

at least 19

not identified in

years old,

this evidenced-

abstracts

based clinical

included,

guideline.

analyses,
clinical trial,

I
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human. The
literature
update for this
edition was
published
between 2015
and 2016. s
Ivers, Jamtvedt,

The purpose of

A systematic

Flottorp, Young,

this systematic

Odgaard-Jensen,
French, … Oxman
(2012).

I

A weighted mean

Although small,

The strength of

review of 140

risk difference of

chart audit and

this study was

review was to

randomized

0.5% to 16%

feedback is

the nature of it

examine the

controlled

increase in

effective in

being a

impact audit and

trials were

provider

improving

systematic

feedback has on

examined,

compliance

healthcare needs.

review of 140

healthcare

which utilized

resulted. 26

The

studies. One

professionals’

audit and

comparisons with

effectiveness is

main limitation

practice and

feedback with

21 studies

impacted by

was that some

patient

healthcare

revealed a

baseline

lack of

outcomes. The

professionals.

weighted median

performance and

documentation

aim is also to

A multivariate

change to control

the system of

may have

examine the

meta-

was 1.3%.

feedback.

caused some

cause of the

regression

differences

was utilized to

between the

evaluate the

reporting bias.
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effectiveness of

differences

various chart

between the

audit and

effectiveness

feedback.

of chart audit
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and feedback.
Ospina, Mrklas,

The purpose of

This meta-

Deuchar, Rowe,

this systematic

Leigh, Bhutani,

I

A total of 14

These discharge

The meta-

analysis

studies were

bundles led to

analysis aspect

review was to

systematic

examined with 26

less

is a major

& Stickland

examine the

review

different elements

readmissions,

strength.

(2017).

efficiency of a

identified

of care. Four

but not

Limitations

discharge COPD

studies that

main trials

necessarily any

include barriers

care bundle.

examined care

revealed that

reduced

and promotors

bundles for

these bundles

mortality or

of the bundle,

discharged

reduced

improved quality

which were not

patients with

readmissions to

of life.

examined.

COPD. One

the hospital. One

Also, possible

of which

of the strategies

bias due to a

included

identified in

lack of

documenting

implementing this

similarity and

spirometry.

bundle was the

blinding may

chart audit and

have been

feedback.

present.
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McClellan,

The aim of this

A randomized

Millman,

study was to

67
II

Claims-based

Chart feedback

The strength

trial of

feedback was

and education

was the

Presley, Couzins, determine if an

randomly

involved in the

regarding A1C

randomized

& Flanders

intervention

selected

intervention.

levels resulted in

aspect as well

(2003).

involving chart

physicians in

Rates for the

improved

as the large

feedback of A1C

a southern

quality indicators

treatment for

sample size.

causes more

American

increased as well

diabetic

An over or

frequent

state were

as the rate of A1C Medicare

underestimation

monitoring.

assigned to

testing from

may have

patients who

13.0% to 16.8%.

patients.

occurred since

met the

indicators were

diabetes

initially

criteria for the

assigned to the

study. The

patients and

patients

then the

sample were

providers.

about 23,000

Another

and the

limitation is that

physicians

the study

were about

occurred only

477 and 123

with rural

counties.

counties in a

After

single state.

SPIROMETRY AND COPD DIAGNOSIS

68

assigning
patients to
physicians,
each county
was placed in
alphabetical
order and
randomly
assigned a
number,
which was
used to assign
to either the
intervention
or control
group.
Thomas,

The purpose of

A total of 78

Thomas,

this study was to

Stroebel,

Patients that were

Using a chart

The RCT aspect

subjects were

treated by the

audit and

of this study

examine the

included in a

intervention

feedback system

was a strength.

Mcdonald,

impact an audit,

randomized

group had an

with providers

The incomplete

Hanson,

feedback, and

controlled

improved

improved

participation of

Naessens, . . .

patient reminder

trial to which

adherence to the

diabetes care

residents, the

39 residents

A1C

processes, but

inability to

Kolars (2007).

II
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system had on

received the

recommendations

did not

calculate the

diabetes care.

instructions,

compared to the

necessarily

impact of

chart audit,

control group.

impact the

interventional

feedback, and

intermediate

components,

letter and 39

clinical results.

and the inability

were in the

to have binding

control group.

because of the
intervention
were all
limitations with
the study.

Guerriero,

The aim of this

A randomized

Caminati, Viegi,

study was to

Senna, Cesana,

II

Pulmonary

Based on the

The random

cross-

symptoms were

prevalence of

aspect of this

evaluate the

sectional

experienced daily

patients with

study is one

& Pomari

prevalence of

study sent

by 26.7% and

COPD, an

main strength as

(2015).

COPD in

5,000

only 30.7% had

underdiagnosis/

well as the

Northern Italy

invitation

previously

misdiagnosis of

population size.

utilizing the

letters and

received

COPD occurs if

Also, the study

GOLD and

1,236 subjects

spirometry. The

underutilizing

utilized

ERS/ATS

were included

COPD prevalence

spirometry. This

different

criteria.

based on reply

depended on the

may affect

criterion, which

and ability to

criteria utilized:

quality of life

is more

perform

11.7% with the

and fiscal

thorough. One
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spirometry.

GOLD criteria,

means that may

limitation is that

Spirometry

9.1% LLN, and

be preventable if

the prevalence

and physician

6.8% physician

spirometry was

is confined to

assessment

diagnosis. Of the

utilized.

one specific

were

subjects

area, which

completed

previously

could limit the

diagnosed, 48.8%

generalizability.

never received
spirometry.

Chapman,

The objective of

A random

Tashkin, & Pye

the study was to

(2001).

III

A hypothetical

Primary care

The random

sample of 192

case study and

physicians

sampling

examine if

primary care

interview was

underdiagnose

method of

gender bias

physicians

provided to the

COPD,

choosing

affected the

completed a

PCP’s and the

especially with

physicians was

diagnosis of

hypothetical

outcome revealed

their female

a strength. A

COPD.

case study and

that COPD was a

patients.

limitation

follow-up

more likely

Spirometry is

included the

interview.

diagnosis to be

underused and

lack of studying

given to a male

may ultimately

real encounters

by 16%.

reduce COPD

with patients
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underdiagnosis

and the

as well as gender

physicians

bias.

background/trai
ning was not
examined.

Walters, Walters, The purpose of

A cross-

Nelson,

this study was to

Robinson, Scott,

III

The subjects were

Basing a COPD

One strength of

sectional

given spirometry

diagnosis on

this study was

quantify the

study was

and the results

symptoms in

that the

Turner, &

number of

completed in

concluded that of

primary care

intervention

Wood-Baker

patients with

31 different

the 341 patients

may be

occurred across

(2011).

COPD who were

practices in

with a COPD

inaccurate,

many different

misclassified in

Australia. A

diagnosis/Tiotropi especially with

practices. A

primary care and

total of 341

um usage, 107

overweight

main limitation

to identify the

patients were

were

patients. The

was that the

causes correlated

eligible for

misclassified.

study highlighted study examined

with the

the study

Misclassification

the importance

patients with

misdiagnoses.

based on their

was shown to be

of utilizing

COPD in

COPD

increased with

spirometry to

primary care

diagnosis or

overweight/obese

prevent improper and not an

prescription

patients and those

management.

for

that have reported

Tiotropium.

allergic rhinitis.

ambulatory
setting.
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Jain, Allison,

The purpose of

A

Andrews, Mejia,

this study was to

Mills, &
Peterson (2015).

72
IV

Of the total 333

Objective

The

retrospective

subjects who are

confirmation is

retrospective

examine the

chart review

considered to be

necessary to

chart study is

misdiagnosis of

with total of

frequent

avoid

the main

asthma/COPD

333 patients

exacerbators,

misdiagnosis of

limitation.

and its factors in

were enrolled

misdiagnosis was

frequent

Also, post-

frequent

in the study

identified in 26%

asthma/COPD

bronchodilator

exacerbators.

based on

of patients. Risk

exacerbations.

spirometry was

inclusion and

factors for

Employing

not done in

exclusion

misdiagnosis

spirometry is

about 15% of

criteria.

include

helpful is

patients and

Patients

underusing

reducing

may have

received

spirometry and

misdiagnoses.

skewed the

various

smoking pack

results. The

diagnostic

years.

strength of this

testing and

study was its

two

incorporation of

pulmonologist

frequent

s made the

exacerbators.

final
diagnoses.
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Gershon, Hwee,

This study

A chart

73
IV

Only 35.9% of

Only about one-

The strength of

Croxford, Aaron, examined the

review

the patients newly third of patients

this study is the

& To (2014).

correlation of

population

diagnosed with

newly diagnosed

large population

patient and

study

COPD had

with COPD

size.

physician factors

examined

spirometry

received

Limitations

with ordering

491,754

completed.

spirometry. The

include the lack

spirometry to

patients that

age, various co-

of certainty of

confirm the

were 35 years

morbidities, and

when the

diagnosis of

of age and

specific

spirometry was

COPD.

older and

physician factors

completed as

newly

have been shown

well as a lack of

diagnosed

to impact the use

indication if the

with COPD

of spirometry.

spirometry was

between 2000

diagnostic in

and 2010.

nature.

Gershon,

The purpose of

A longitudinal IV

Patients with

Confirming the

A strength to

Mecredy,

this study was to

population

COPD who

diagnoses of

this study was

Croxford, To,

determine if

study between

received

COPD utilizing

the large

Stanbrook, &

completing

2005 and

spirometry had a

spirometry is

population size,

Aaron (2017).

spirometry to

2012 included

9% lower risk of

correlated with a

but limitations

confirm a COPD

68,898

mortality and

decreased risk of

include

diagnosis was

patients who

hospital

mortality as well

misclassificatio

correlated with

had COPD

as admissions to

n, bias, and
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improved health

and were

admission rate for

the hospital for

confounding

outcomes.

older than 42

COPD.

COPD.

factors. Also,

years old.

an association
between
spirometry and
patient
outcomes may
not necessarily
indicate
causation.

Wu, Wise,

The purpose of

A

Medinger,

this study was to

(2017).

Of the 826

Without

One specific

retrospective

subjects, 21%

spirometric

limitation is that

examine the

longitudinal

never had

confirmation of

of the 826

frequency that

study between

spirometry

COPD, issues

patients, 12% of

patients are

2005 and

completed and

with

the patients who

discharged with

2015

only 56% had

hospitalizations,

received the

a COPD

examined 826

obstruction

readmissions,

spirometry were

diagnosis that

patients

identified through

quality of care,

unable to

was confirmed

hospitalized

spirometry.

and resource

complete the

by spirometry at

for COPD at

waste will be

breathing

the Veterans

the VA.

negatively

maneuvers

impacted.

accurately.

Affairs (VA)
system.

IV
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Mapel, Dalal,

The purpose of

A

Johnson, Becker,

this study was to

& Hunter (2015). examine primary

75
IV

The subjects

The study

The strength of

randomized,

received a

concluded that

this study was

multicenter,

questionnaire and

without

that the design

care physicians’

cross-

spirometry. The

spirometry,

as randomized

impressions of

sectional,

primary care

underestimations

multicenter.

the severity level

observational

physicians

of COPD

The limitations

of their patients

study

completed a

severity occur.

of this study

with COPD.

recruited 899

questionnaire and

Also, about one-

include it being

The study also

patients with

case study forms.

third of these

observational

attempted to

COPD in 89

The physician’s

patients with

and recruiting

examine if

practices.

impressions of

COPD received

physician’s with

spirometry

severity for their

treatment

a previous

results impacted

patients were only changes after

interest in

the physicians’

30% accurate

they received

COPD and

viewpoint and

with 41% of the

spirometry.

experience

treatment

severities being

Therefore,

treating COPD.

choices.

underestimated.

spirometry is a

Also, the

About 30% of

helpful tool in

terminology of

patients received

primary care for

the severity of

a change in their

diagnosing and

COPD is

severity after

accurately

considered

spirometry, and

treating COPD.

subjective in

37% of treatments

nature, which
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were changed by

may have

physicians based

skewed the

on the severity

results.

levels.
Fortis, Corazalla, The purpose of

A

Jacobs, & Hyun

this study was to

(2016).

IV

About 7% of

Persistent COPD

Limitations

retrospective

these patients had

empiric

include the

determine the

chart review

an empiric COPD

diagnosis and

retrospective

number of

ensued

diagnosis and

treatment still

aspect as well

people who

including

24% had an

occurs despite

as being

receive a

1,805 subjects

empiric treatment. spirometry

persistent

with

results indicating

one healthcare

empirical COPD

Spirometry.

no obstruction.

system. Despite

operated in only

diagnosis and

the limitations,

treatment as well

the

as identify

overdiagnosis

factors that

and

contributed to

overtreatment

the empiric

of COPD needs

diagnosis and

to be further

treatment of

evaluated and

COPD despite

managed.

spirometry and
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lung volume
measurements.
Asche, Leader,

The purpose of

An

Plauschinat,

this study was to

Raparla, Yan, &
Young (2012).

IV

Adhering to the

Staging of

Measuring the

observational,

GOLD standards

COPD utilizing

fiscal aspect of

measure the

retrospective,

showed an

spirometry and

this study was a

potential fiscal

cohort study

average fiscal

adhering to the

strength. The

savings for

ensued with

savings of $5,889

GOLD standards

main limitations

adhering to

761 subjects

for LAMA +

was correlated

include possible

GOLD standards

who were

LABA treatment

with more fiscal

discrepancies

to treat COPD.

chosen based

group, $3,330 for

savings with

with gathering

on inclusion

LABA + ICS

moderate to

information

criteria.

group, and

severe staged

from the EMR.

$10,217 for

COPD.

Therefore, the

LAMA + LABA

Appropriately

true cost of

ICS group.

prescribing

treatment may

inhalers impacts

be higher than

not only clinical,

reported.

but also fiscal

Secondly, the

responsibility.

inclusion/exclus
ion criteria
resulted in a
relatively small
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number of
subjects.

Spero, Bayasi,

The purpose of

A total of

Beaudry, Barber,

this study was to

& Khorfan
(2017).

IV

Spirometry

Up to one-third

The main

6,018 patients

confirmed the

of patients

limitation of

examine the

were

COPD diagnosis

admitted with

this study was

prevalence of

examined

for 69.2% of

COPD to the

that it was

spirometry usage

through a

patients.

hospital may be

conducted in

and to assess the

retrospective

Restrictive lung

misdiagnosed

one center and

accuracy of the

chart based on

disease was

based on

it was

diagnosis of

their age

identified in

spirometry

retrospective in

patients

being greater

26.6% and 4.2%

results. Factors

nature. The

hospitalized for

than 18 and

were normal.

correlated with

main strength of

COPD.

having a

Factors correlated

misdiagnosing

this study was

COPD

with obstruction

COPD include

that it was
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diagnosis. Of

include smoking

an elevated BMI, conducted with

these patients,

status as well as

other co-

real-world

a total of 390

an elevated pack-

morbidities, and

situations in a

had adequate

year history.

a lower pack-

local

spirometry

Patient factors

year smoking

community

based on

correlated with

history.

teaching

ATS-ERS

misdiagnosing

criteria.

COPD include an

Other data of

elevated BMI and

the patients

other co-

were collected

morbidities.

hospital.

including
their smoking
status and
BMI.
Walker,

The purpose of

A

Mitchell,

this study was to

Diamantea,

IV

Of the 1,508

Spirometry

Limitations

retrospective

patients referred,

increases the rate

include its

examine if

review

130 received a

of COPD

retrospective

Warburton, &

spirometry usage

examined a

new diagnosis,

diagnosis and

review. An

Davies (2006).

in primary care

total of 1,508

most of which

also results in

important

to diagnose

subjects who

was COPD.

improved

strength was the

COPD would

were referred

These patients

treatment.

random

for open-

with COPD were
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improve

access

found to be

selection of

management.

spirometry.

undertreated and

practices.

Exclusions for

spirometry

referral

resulted in an

include <40

increase in using

years of age

pharmacologic

and no history

treatment for

of smoking.

these patients.

Casas Herrera,

The aim of this

This

Montes de Oca,

study was to

López Varela,
Aguirre, Schiavi,

Spirometry was

COPD

multicenter,

initiated with

underdiagnosis is include the

examine COPD

international

these patients and

a major issue in

possible

under/misdiagno

study was

the results

primary care.

overestimation

conducted in

examined. COPD Spirometry

of COPD

primary care.

Latin

underdiagnosis

usage should be

underdiagnosis

Also, the aim

America, in

was 65.8% and

encouraged and

in the study.

was to determine

which

misdiagnosis was

available to

Also, the results

26.4%.

primary care

obtained may

& Jardim (2016). sis rates in

factors correlated subjects were

IV

Limitations

with COPD

included in

patients to

not pertain to all

underdiagnosis.

the study if

reduce

countries in

they were >40

underdiagnosis.

Latin America.

years and at

However, one

risk for

particular

COPD. A

strength is its

SPIROMETRY AND COPD DIAGNOSIS

81

total of 1,540

international

subjects were

aspect.

included in
the study.
Ghattas, Dai,

The purpose of

A

Gemmel, &

this study was to

Awad (2013).

IV

Of the 80

Without

Some

retrospective

subjects,

spirometry,

limitations

identify the

descriptive

spirometry

COPD

include patient

patients that are

cohort study

showed 42.5%

overdiagnosis

recall bias, data

over diagnosed

examined 80

had no

occurs at a high

input error, and

with COPD and

patients who

obstruction,

rate. Confirming the low number

subsequently

were

22.5% had a

a COPD

of subjects.

mistreated.

previously

reversible

diagnosis with

One main

diagnosed

obstruction, and

spirometry is

strength is that

with COPD or

35% had non-

necessary to

the spirometry

prescribed an

reversible

prevent

was completed

anticholinergi

obstruction.

mistreatment,

based on

c inhaler

prevent using

recommendatio

without a

incorrect

ns of the

COPD

medications with

American

diagnosis.

possible side

Thoracic

Patients were

effects, and

Society.

referred for

avoid

spirometry to

unnecessary
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confirm their

costs, especially

COPD

in populations

diagnosis or

with fewer

assess

health resources.

severity of
diagnosis.
Jagana, Bartter,

The purpose of

This article

& Joshi (2015).

this article was

V

Ironically, COPD

The early

Its limitation is

examined

is both under and

diagnosis of

that it is only a

to identify the

several

over diagnosed.

COPD needs to

level V

causes and

studies and

be examined

evidence, but

solutions for the

literature

further and

one strength is

delay in COPD

regarding

requires a culture that it examined

diagnosis.

COPD

change in

multiple studies

diagnosis

primary care.

to make

delays.

Respiratory

conclusions

symptoms in a

about COPD

smoker over the

and its

age of 40 should

diagnosis delay.

be emphasized in
that they need
spirometric
evaluation.
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